Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Procedure Uses Novel ‘Paper-Clip’ Style Device to Treat High Blood Pressure

September 20, 2013 By University of Leicester

University of Leicester and Glenfield Hospital consultant carries out first operation with innovative implant

Researchers at the University of Leicester and Glenfield Hospital have successfully used a novel “paper-clip” sized vascular coupling device to tackle resistant high blood pressure.

The operation was carried out on Monday 16 September at Glenfield Hospital by Professor André Ng, Professor of Cardiac Electrophysiology at the University of Leicester and Consultant Cardiologist at Glenfield Hospital.

The trial – called ROX CONTROL HTN – is a prospective randomized international multicentre study designed to evaluate a novel treatment, called the ROX coupler, in patients with resistant hypertension. The ROX Coupler is a small metal stent made of nitinol which when deployed, acts like a “paper-clip” joining an artery and a vein together in the groin area (called iliac vessels). This allows blood to flow between the high pressure artery and the low pressure vein. The Coupler is inserted and put in place via key-hole procedure at the groin under local anaesthesia.

Professor Ng said: “Our research at the University of Leicester aims to find novel ways of tackling hypertension.

“We carried out this procedure on our first patient, a 56 year old male, here at Glenfield Hospital, which went extremely well. After the initial preparation, it took me and my team just over an hour to put the implant in place. Almost immediately the patient’s blood pressure went down to more acceptable levels which we anticipate to further improve with time. The patient was kept overnight for observation but will be discharged the following day if everything is well.”

“Results from the pilot study already done on this new technology look promising. There is a very early response with a reduction in blood pressure in resistant hypertensive patients which appears to be maintained in medium term at least. We hope to uncover the mechanisms by which this works and that is the whole purpose of the randomised trial to establish the safety of this new technology, the characteristics of the response and more insight into the way it works.

The patient, from Leicester, said: “The procedure is remarkable. I know it is still early days but I have already seen a significant reduction in my blood pressure points. I am amazed!”

Professor Ng added: “Uncontrolled hypertension can lead to many other medical conditions with dire consequences. Patients with resistant hypertension have blood pressure way above normally accepted levels despite multiple medications in combination. New forms of effective treatment are always welcome and that is the reason why we, at the University of Leicester and Leicester’s Hospitals, are conducting properly designed trials to assess the efficacy.

“We hope this groundbreaking treatment will provide a lifeline to patients who have had all the drugs prescribed and yet their blood pressure remains uncontrolled.  It is an example of how research at the University of Leicester is being applied to benefit patients at Glenfield Hospital. We also really like the fact that the procedure is reversible.”

Professor Ng said: “It is clear that a novel approach beyond the use of drugs needs to be developed to treat this condition. That is why this trial between the University of Leicester and Leicester’s Hospitals is so important.”

The study is conducted at Leicester with the support of the National Institute for Health Research (NIHR) Leicester Cardiovascular Biomedical Research Unit (BRU). The ROX CONTROL HTN study is sponsored by ROX Medical (San Clemente, California, USA), the developer of the ROX coupler device.

Professor Ng leads studies in the novel therapeutic interventions theme of the National Institute for Health Research Leicester Cardiovascular Biomedical Research Unit and has previously carried out the world’s first remote heart procedure using a robotic arm alongside 3-D mapping in 2010 and also UK first implant of a novel vagus nerve stimulator in heart failure in 2012.

Related Articles Read More >

A photo of Capstan Medical's mitral valve implant, which uses nitinol.
Capstan Medical’s R&D head discusses the heart valve and robotics startup’s tech, engineering challenges and solutions, advice for others in medtech and how to join his team
An illustration of a neurosurgeon using a robotic endoscope to remove a brain tumor.
MDO Nitinol Innovation Special Report
A photo of Highridge Medical CEO Rebecca Whitney.
Highridge Medical is betting on this spine tech
A photo of the miniature Auxilium Biotechnologies implants made on the International Space Station.
Implants 3D-printed in space could enable nerve regeneration
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe